Technology | 2019.02.27
Bolt Biotherapeutics To Present Preclinical Proof of Concept Data at American Association for Cancer Research (AACR) Conference
REDWOOD CITY, Calif., Feb. 27, 2019 /PRNewswire/ -- Bolt Biotherapeutics, Inc., a biotechnology company focused on unleashing the power of the immune system to achieve anti-tumor immunity in patients with its promising Immune-Stimulating Antibody Conjugate (ISAC) platform, today announced ...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]aacr-conference-300803639.html
Follow us on
Instagram is adding automatic in-app text translation - The Verge views: 1568
Instagram is adding automatic in-app text translation - The Verge views: 1507